j Summary: Reliability of test results, convenient handling and flexibility are major requirements on automated ! immunoassays systems. To investigate to what extent these requirements were met by the Pharmacia CAP and DPC IMMULITE and DPC Microplate Systems, we evaluated several performance characteristics of assays of specific IgE against some common inhalant allergens as well as the atopy tests Phadiatop (Pharmacia CAP System) and AlaTOP (DPC IMMULITE and Microplate System).
Introduction eludes the test AlaTOP allows random access allergy
Automated systems in our laboratories are expected to screening testin S and would reduce P re 3η3ΐ^ίθ31 work be easy to handle and as flexible as possible to enable lme ' laboratory personnel to work with them at all times. The AlaTOP IMMULITE and follow up with allergen sperecently introduced IMMULITE (DPC) (1,2) which in-cific IgE tests on a DPC Microplate automated micro-plate system (DPC) could be an alternative to the Pharmacia CAP System presently used in one of our laboratories for differential as well as specific allergy testing in the following configuration: RoboCAP, Auto-CAP and FluoroCount 96. Studies performed previously (3, 4) usually compared performance to the skin prick test (SPT). In this study we wanted to examine the performance of both systems from a quantitative standpoint.
The need for initial differential tests is indicated in several studies (5, 6, 7) . The quantitative measurement of specific IgE antibodies has been proposed as a basis to correlate severity of disease with serum concentration of IgE antibodies (8, 9) . This has also been expressed as a preference by the clinicians at and around Maaslandsziekenhuis, Sittard. The aim of the study was to investigate the performance characteristics of the tests run on the combination of two DPC systems as compared to Phadiatop and specific IgE antibody assay on the Pharmacia CAP System.
The following performance characteristics were evaluated:
-clinical sensitivity and specificity of AlaTOP in the two DPC systems and of Phadiatop® -within, between and total assay run precision -systematic differences between the specific IgE assays -consistency after dilution -interference from allergen specific IgG antibodies -influence from unspecific IgE.
Furthermore the systems were evaluated with respect to user friendliness.
Materials and Methods

Test technologies
The Pharmacia CAP System FEIA is a fluorescent enzyme immunoassay. The allergens, covalently coupled to the Immuno-CAP, react with the specific IgE in the patient serum and enzyme labelled anti-IgE antibodies are added to form a complex. This is incubated with a development agent. When the reaction is finished the fluorescence is measured.
The DPC Microplate System is an enzyme immunometric assay based on liquid ligand labelled allergens and separation by ligandcoated wells. The specific IgE in the patient sample forms an allergen-IgE complex which is incubated with a multivalent anti-ligand which in turn links the allergen-lgE complexes and the ligandcoated wells. Horseradish peroxidase labelled monoclonal anti-IgE antibodies are added to the allergen-lgE complex. A chromogenic indicator is added and the result is measured kinetically.
IMMULITE is a chemiluminescent enzyme immunoassay, based on the same principle as Microplate but utilising an alkaline phosphatase-labelled anti-human IgE which reacts with a chemiluminescent substrate. Anti ligand coated polystyrene beads are used to capture the ligand labelled allergens.
WHO-IgE based calibrators are used for determination of total JgE and values expressed in kU/1. In Pharmacia CAP System these standards are also used for the determination of specific IgE antibodies and the values are expressed in kU A /l. For study purposes we have used kU/1 as the measuring unit for both systems. For further details of the different test systems, see the directions for use from the system suppliers. 
Instruments and reagents
Pharmacia CAP System instruments and reagents
RoboCAP
Evaluation of precision
The standard deviations of the error components within and between runs were estimated from analysis of variance and are presented as coefficients of variation, CY(%), i.e. the standard deviä-Eur J Clin Chem Clin Biochem 1995; 33 (No 5) tion in per cent of the mean, As an estimate of a common CV for all species, the pooled CV is calculated according to CV,.,, Pooled Ί + cvs,+ cvSs + 6 jft+ cy&
Precision experiment
Allergen specific IgG antibodies against the allergens dl, el, e5, go, t3 and w6 were assayed in one sample per allergen in five replicates in each of the five runs.
Comparison of methods
The results from the method comparison arc presented graphically in xy-plols. Straight lines have been fitted to the xy-plots according to the method by Passing & Bahhk (12) (13) (14) . As pointed out by Altman & Bland (15) , it may be more relevant to consider the differences or ratios between the methods and therefore ratio plots, y/x against (x + y)/2, arc also presented. By applying the statistical analysis suggested by Nilssou (16) the existence of sample-related differences can be tested and their standard deviations estimated. To facilitate the interpretation the standard deviation of the samplerelated differences is expressed in relation to the expected contribution to the scatter from the random variation within runs, i.e. by the quotient between the two standard deviations, in this paper denoted as the coefficients of sample-related disagreement, CSD. This coefficient gives the relative importance between sample-related differences and the variation within runs when results from the two methods are compared. A value of CSD > 0.75 corresponds to the rule of thumb given in 1. c. (16) for rejection of the hypothesis of no sample-related differences (with a significance level υΓ5% or less). A CSD > 1.5 should be considered an indication of a crucial contribution to a disagreement between the methods from sample-related differences.
As relative differences are more relevant than absolute ones, the statistical analysis is performed after logarithmic transformation of the concentrations.
Experimental Design
Estimation of clinical sensitivity and specificity of AlaTOP and Phadiatop Serum samples from 100 consecutive patients with suspected allergy were used to assess clinical sensitivity and clinical specificity. 34 were clinically verified as atopic and 61 as non-atopic, while in 5 cases, clinical history and available in vivo test results were inconclusive. The latter were excluded from the comparison. The following alternative criteria were used for positive diagnosis of atopy; SPT of 3+ (equal to wheal of histamine control, 10 g/1), SPT 24-in combination with positive case history for the same allergen, SPT 1+ or 2+ in combination with positive RAST for the same allergen or a positive provocation test. The criteria for a negative diagnosis of atopy was; SPT negative, SPT 1 -I-in combination with negative case history or negative RAST or negative provocation test. Patients not fulfilling criteria for positive or negative atopy diagnosis were considered as inconclusive.
Age:
Average 28 years, range 17-67 years Sex:
60 females and 40 males Diagnosis:
41 Bronchial asthma, 19 Seasonal rhinitis and 63 Perennial rhinitis.
The serum samples were tested with Phadiatop (Pharmacia CAP System) and AlaTOP (IMMULJTE and DPC Microplate System).
Evaluation and comparison of performance characteristics for measurement of specific IgE antibodies
All assays were allocated to five runs consisting of two plates and evaluated with a separate calibration curve and performed during a five day period. All samples were coded and assayed blind.
Evaluation of systematic differences
62 patient sera per allergen (dl, el, e5, g6, 13 and w6) were selected according to the results with our current routine method (Pharmacia CAP System) and used to assess the possible concordance between DPC Microplate system specific IgE Microplate (DPC Microplate System) and RAST (Pharmacia CAP System).
Dilution experiments
Two patient sera for each of the allergens dl, cl, c5, go, t3 and w6 were diluted and assayed in duplicate, undiluted and diluted with negative serum to 1:2, 1:4, 1:8 and 1:16. The diluent consisted of pooled human serum from healthy controls, presenting responses below 50% of the cut-off in both systems and a concentration of total IgE of approximately 5 kU/l. AJI dilutions were made independently from the origin sample. All assays were allocated to the same run. The 100 kU/l calibrator wus also diluted and assayed in the same way for the two systems, respectively.
Addition experiment: IgE
One negative control serum per allergen (dl, el, e5, g6,13 and w6) and method was spiked with myeloma IgE to total IgE levels of approximately 1000 and 3000 (kU/l) units to test for unspecified binding of IgE protein. All samples were assayed in duplicate in the same run.
Addition experiment: Allergen speci c igG antibodies
Allergen specific rabbit antisera were diluted with normal rabbit scrum to 1 :2, 1:4 and 1 : 8. One patient serum for each of the allergens dl, go and t3 was mixed in equal pans with negative human serum, normal rabbit serum, the undiluted and the three dilutions of the anti sera, Thus a series of six samples with the same proportion of the patient serum is obtained. One is diluted by human negative serum and the other five contain the IgG antibodies (rabbit antiserum) in the proportions 1 : 2, I : 4, I : 8, I : 16 and 0. All six samples for each allergen were assayed in duplicate in the same run. This experiment shows relative differences in risk for interference by non-lgE antibodies competing for the same allergen and may be considered as a test of the capacity of the allergen reagent.
Comparison of calibrators
The assigned values of the calibrators were checked for both systems by assaying the DPC Microplate System calibrators in duplicate in the Pharmacia CAP System and vice versa.
Results and Discussion
Clinical performance of Phadiatop and Ala-TOP
The results for Phadiotop (Pharmacia CAP System) and AlaTOP (IMMULITE and DPC Microplate System) are (17) (18) (19) . A differential diagnostic test for atopy is often the first test to be performed on a patient and is followed by allergen specific testing in the cases considered atopic i. e. in those cases with positive Phadiatop/AlaTOR It is obvious that high sensitivity is essential in this situation.
• t
Technical performance of specific IgE test systems
Precision
The random variation expressed as total CV as well as the variation within and between runs for the DPC Microplate System were more than twice as high as for the Pharmacia CAP System (see tab. 2, trial 1). The obtained results (kU/1) in trial 1 were also higher with the Pharmacia CAP System than with the DPC Microplate System, apart from go where the figure was obtained by extrapolation by the DPC software.
In order to rule out a faulty instrument as the cause of imprecision (tab. 2, trial 4 only DPC) and to compare the precision in the lower part of the measuring range (tab. 2, trial 2, 3) a second investigation was performed with the Pharmacia CAP System and manually (without Mark V pipette) with the DPC System. This showed a similar relation between the systems in terms of coefficient of variation as in trial 1. In trial two, three and four, new sets of sera were used, so no correlation between the trials was possible.
The Mark V instrument might contribute to a general increase of the imprecision* but random variation of the size shown by the DPC Microplate System makes testing with single determinations questionable.
Systematic differences
The calibrator range for both methods is 0.35-100 kU/1. The distribution of results below, within and above the measurement range with the two methods is given in table 3.
' A high number of samples, between 4% and 16% for j the different species, were reported as above the highest standard point in the DPC Microplate System. The reason for this can not be deducted from this experiment but the high variation, the unpredictable behaviour of serum samples and the calibrator in the dilution experiments and the need for individual optimisation of the allergen reagents are probably major contributing factors.
A first comparison between methods was performed on a class basis and showed the agreement between nega- Cases with discrepant results in the low range (tab. 3 and fig. 1 ), i.e. measurable with the Pharmacia CAP System but not with the DPC Microplate System and vice versa, were further studied by immunoblotting.
The twelve samples which were Pharmacia positive and DPC negative had specific IgE values in the range of 0.75-12.1 kU/1, eight of these were still available and sent to Pharmacia Diagnostics for analysis. In seven of eight cases presence of allergen specific antibodies could be demonstrated and optical density of blotting pattern scanned, see figure 1 . The IgE antibodies were found to represent major as well as minor allergenic components of house dust mite, cat dander, timothy pollen and mugwort pollen (Pharmacia, personal communication). In the remaining case, serum no. 80, not present in figure 1 , very week staining corresponding to the major mugwort allergens could be seen but not recorded because of limitations of sensitivity in the scanning equipment. All the cases with positive Pharmacia CAP System readings were confirmed by the analysis of IgE antibodies against individual allergenic components.
Two sera, no. 174 and no. 267, resulted in DPC positive and Pharmacia negative results. IgE antibodies detectable in the Western blot procedure were reported for timothy pollen, birch pollen, mugwort pollen and cat epithelia. No immunoblotting figures were included in the communication (DPC, personal communication).
Quantitative evaluation of systematic differences
For investigation of quantitative agreement between the methods both plots of y (DPC) versus χ (Pharmacia) and of y/x (on a logarithmic scale) versus (x + y)/2 are given in figure 2 . The estimated straight lines and coefficients of correlation for the xy-plots according to Passing & Bablock are given in table 4. Overall there is a low correlation between the methods. In order to examine the disagreement between the methods the suggestions put forward by Nilsson (16) were followed. Only samples with both results within the calibrator range were included. From the precision experiment, with go excluded for the DPC Microplate System (above range), the expected standard deviation of the scatter expressed in In (concentration) was estimated as 0.22. No indication of dependence between differences and concentration level was obtained and the mean difference expressed in per cent of the result with the Pharmacia CAP System was calculated. These values and the CSD-values (the coefficient of sample-related disagreement) are given in table 5. For all allergens the sample-related differences are significant and as can be seen in table 5 the CSD-values are substantially greater than 1.5. This indicates that the error contribution from sample-related differences far exceeds the analytical variation presented in table 2.
Although an xy-plot may indicate a correlation between the methods, a ratio plot shows that the disagreement is considerable. From the ratio plot for dl for example, it is evident that the ratio y/x varies between 10 and 300%.
The sample-related differences are probably caused by different capabilities of the two test systems to measure individual mixtures of IgE antibodies against the allergenic components of an allergen. Furthermore, as the observed mean differences of the DPC Microplate System vary between -25% for go and + 110% for e5, differences between the allergens also in terms of calibration can hardly be excluded. On the contrary, it is very likely that a variable calibration error is introduced in a system where each individual allergen-reagent lot must be adjusted to an optimal signal level (DPC) rather than to allergen excess (Pharmacia).
It is obvious from the study of systematic differences that several samples with clearly measurable levels of IgE antibodies remain undetected by the DPC Microplate System. This fact and the observation that many cases with low to moderate levels show lower levels with DPC, is in concordance with the sample related differences between methods discussed above. Insuffi- 
Effect of addition of competing IgG antibodies
The values obtained for sera mixed with negative rabbit serum are referred to as expected values (E) and the observations of all other mixtures (O) are expressed as O/E. The mixtures with negative patient serum are used to check whether dilutions with negative patient and rabbit serum respectively can be considered as equivalent.
The obtained values of O/E for these mixtures are in the range 86-107% for Pharmacia and 85-120% for DPC, i. e. well within the range of random variation. For the mixtures with rabbit serum O/E-values are plotted against percent of rabbit IgG serum in the sample. As can be seen from figure 4 , the Pharmacia CAP System gives a moderate decrease for increasing amounts of rabbit IgG while the effects in the DPC Micrpplate System are varying and more dramatic. The results may be explained by the fact that liquid allergens can be aggregated by allergen specific IgG antibodies present in the serum sample (Personal communication, PDC). the data also support the observations made in the evaluation of systematic differences suggesting insufficient allergen excess in the DPC system. cient excess of allergen and/or missing allergenic components in the DPC system reagents are the most probable causes for such a deviation.
Effect of dilution
The ratios between observed (O) and expected (E) values for all diluted samples were calculated. Plots of O/E against dilution give a rather regular pattern for the Pharmacia CAP System while the DPC Microplate System exhibits more dramatic effects and very irregular patterns as illustrated in figure 3 . Due to the irregular pattern shown by DPC it is not relevant to fit a model to the relationship between O/E and dilution and the results can hardly be summarized numerically in any meaningful way. Dilution of the calibrator 100 kU/1 also showed an irregular pattern, which was confirmed in a repeated experiment. The unpredictable result may, according to the manufacturer, be an effect of interference by auto-anti-IgE, affinity dependent variation in a nonexcess situation or an under representation of rare allergenic proteins in the allergen reagent.
Effect of addition ofunspeciflc IgE
All values are below the measuring range, i. e. < 0.35 kU/1. Thus, addition of unspecific IgE up to 3000 kU/1 does not interfere with specific IgE measurements in the systems under study.
Comparison of calibrators
The results of the DPC calibrators assayed in the Pharmacia CAP System and the Pharmacia calibrators assayed in the DPC Microplate System are shown in For DPC IMMULITE, the first results were obtained after l h 15 minutes, the time for 50 results was 2 h 7 minutes. This shows a theoretical time advantage when using the system for differential testing but in practice no advantage in using the DPC IMMULITE AlaTOP for allergy screening instead of the Pharmacia CAP System Phadiatop was found, RoboCAP is the more flexible and easier to operate instrument when comparing the two systems or system combinations, Pharmacia CAP System to DPC Microplate System and IMMULITE, we find Pharmacia CAP System to be easier to handle as well as to adapt to sample and information flow in our laboratory.
Conclusions
We found no advantages to the combination of two DPC systems from a handling and work flow point of view. Moreover the Pharmacia CAP System is easier to work with than the DPC Microplate System. Comparing Phadiatop and AlaTOP and investigating the specific IgE antibody assays and their capability to meet our quality demands and the need of quantitative measurement expressed by clinicians, we conclude the following:
Eur J Clin Chem Clin Biochcm 1995; 33 (No 5) Phadiatop has a slightly higher sensitivity than AlaTOP either on IMMUL1TE or on D^C Microplate System. Both tests perform as expected from the literature (5-7). But from a screening point of view high sensitivity is preferential. The DPC Microplate System was shown to be less accurate when compared with the Pharmacia CAP System. This is true for moderate and higher concentrations, where we found 2.5 times higher CV's. But at concentrations below 3.5 kU/1 the DPC Microplate System shows, in general, higher CV's. The comparison of results show that the two methods do not, to the full extent, measure the same antibodies. This can be concluded based on the results of the correlation/regression (Passing, Bablok) but more clearly based the study of the sample related disagreement (CSD).
Furthermore DPC failed to detect specific IgE in at least 12 out of 187 patient samples which were in 8 cases found positive with Pharmacia CAP System and confirmed with blotting experiments. In contrary only 2 samples that were positive by DPC Microplate System and confirmed by blotting were found negative in Pharmacia CAP System. 35 results out of the 187 patient samples were above the calibrator range in the DPC Microplate System. The corresponding figure for the Pharmacia CAP System was 1 result.
There was no effect when adding non-specific IgE to serum samples and the comparison of calibrators show a good agreement. When looking at the addition of competing IgG antibodies we demonstrated a moderate decrease in binding of specific IgE in Pharmacia CAP System.
The effect in the DPC Microplate System was more pronounced with large decreases or increases of measured values even at lower concentrations. The results may indicate insufficient allergen concentration in the DPC assay and draw attention to the risk for undesirable complex formation between allergen and antibody in solution.
Finally we conclude that the Pharmacia CAP System provides quantitative measurement of allergen specific IgE antibodies with acceptable analytical variation (Pooled CV « 10%), whereas the DPC Microplate Sys- tem results in higher variation and unwanted side effects when diluting and interfering with IgG. There also seem to be some problems with stability of the specific IgE test. The data obtained in this study support the statement that allergen excess is needed for accurate measurement of IgE antibodies. Even though the reagent prices are marginally higher, we prefer the Pharmacia CAP System for differential as well as specific IgE testing.
